SCHEMBL1906473

SCHEMBL1906473

CC(C)(C)Nc1ccccc1C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLCN2 P51788 1/20 0.53
FABP4 P15090 2/20 0.52
KMT2A Q03164 6/20 0.50
MEN1 O00255 5/20 0.50
AKR1C3 P42330 4/20 0.50
ALDH1A1 P00352 3/20 0.50
AKR1B10 O60218 3/20 0.50
PTGS2 P35354 3/20 0.50
AKR1C2 P52895 3/20 0.50
AKR1C1 Q04828 3/20 0.50
LMNA P02545 3/20 0.50
ABCB11 O95342 2/20 0.50
CHRM1 P11229 2/20 0.50
PTGS1 P23219 2/20 0.50
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2C9 P11712 2/20 0.50
AKR1B1 P15121 2/20 0.50
HIF1A Q16665 2/20 0.50
TRPA1 O75762 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21042963 0.85 CLCN2 (0.50) CLCN2FABP4KMT2AMEN1AKR1C3
SCHEMBL25055219 0.85 TAS2R14 (0.53) CLCN2FABP4KMT2AMEN1AKR1C3
SCHEMBL13788818 0.84 PDK1 (0.54) AKR1C3AKR1B10AKR1C2AKR1C1LMNA
SCHEMBL13911908 0.83 NPC1 (0.53) CLCN2KMT2AMEN1AKR1C3ALDH1A1
SCHEMBL8818967 0.83 KMT2A (0.58) KMT2AMEN1AKR1C3ALDH1A1USP2
SCHEMBL7223232 0.82 KDM4E (0.54) CLCN2KMT2AMEN1ALDH1A1HPGD
SCHEMBL5511334 0.80 FABP4 (0.52) CLCN2FABP4KMT2AMEN1AKR1C3
SCHEMBL3843266 0.80 FABP4 (0.52) CLCN2FABP4KMT2AMEN1ALDH1A1
SCHEMBL769767 0.79 ELANE (0.51) CLCN2KMT2AALDH1A1LMNAHPGD
SCHEMBL28482318 0.78 CLCN2 (0.55) CLCN2FABP4KMT2AMEN1AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119661473-A Method for synthesizing beta-sulfur trifluoromethyl alkylamine by olefin difunctional reaction 东北师范大学 2025-03-21 CN claimed
CN-115453073-A Method for rapidly evaluating safety of benzoic acid compound to water environment 上海应用技术大学 2022-12-09 CN claimed
CN-111346082-A Application of benzoic acid compound in preparation of medicine for treating acute leukemia 上海应用技术大学 2020-06-30 CN claimed
US-9365596-B2 Method for preparing quaternary phosphonium salts MICROVAST POWER SYSTEMS CO., LTD. (CN) 2016-06-14 US claimed
US-20150166587-A1 METHOD FOR PREPARING QUATERNARY PHOSPHONIUM SALTS MICROVAST POWER SYSTEMS CO., LTD. (CN) 2015-06-18 US claimed
EP-3416176-B1 ELECTROLYTE SOLUTION FOR ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR UTILIZING SAID ELECTROLYTE SOLUTION SANYO CHEMICAL IND LTD (JP) 2026-01-07 EP disclosed
CN-119661473-A Method for synthesizing beta-sulfur trifluoromethyl alkylamine by olefin difunctional reaction 东北师范大学 2025-03-21 CN disclosed
WO-2024090362-A1 CHARGE-TRANSPORTING COMPOSITION 日産化学株式会社 2024-05-02 WO disclosed
EP-3480835-B1 ELECTROLYTIC SOLUTION FOR ELECTROLYTIC CAPACITOR, AND ELECTROLYTIC CAPACITOR SANYO CHEMICAL IND LTD (JP) 2022-12-21 EP disclosed
US-11527365-B2 Electrolytic solution for electrolytic capacitor, and electrolytic capacitor SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2022-12-13 US disclosed
CN-115453073-A Method for rapidly evaluating safety of benzoic acid compound to water environment 上海应用技术大学 2022-12-09 CN disclosed
US-11424078-B2 Electrolytic solution for electrolytic capacitor, and electrolytic capacitor SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2022-08-23 US disclosed
EP-0291074-B1 PROCESS FOR PRODUCING QUATERNARY SALTS MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1992-01-29 EP disclosed
EP-0246825-B1 QUATERNARY SALT SOLUTION ELECTROLYTE FOR ELECTROLYTIC CAPACITORS MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1991-02-27 EP disclosed
US-4892944-A Process for producing quaternary salts MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1990-01-09 US disclosed
EP-0291074-A2 Process for producing quaternary salts MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1988-11-17 EP disclosed
US-4774011-A Electrolyte for aluminum electrolytic capacitor MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1988-09-27 US disclosed
US-4715976-A QUATERNARY AMMONIUM SALT OF CARBOXYLIC ACID IN APROTIC SOLVENT MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1987-12-29 US disclosed
EP-0246825-A2 Quaternary salt solution electrolyte for electrolytic capacitors MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1987-11-25 EP disclosed
US-4175184-A Manufacture of 2,1,3-thiadiazin-4-one-2,2-dioxide derivatives BASF AKTIENGESELLSCHAFT (DE) 1979-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166587-A1 METHOD FOR PREPARING QUATERNARY PHOSPHONIUM SALTS PHPT1, PHOSPHO1, PTEN CLCN2 1561/4885FABP4 4643/4885KMT2A 2330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.